loader image
Friday, November 28, 2025
71 F
McAllen
- Advertisement -

Higher Blood Caffeine Levels Linked to Lower Obesity & Osteoarthritis Risk

Translate to Spanish or other 102 languages!

New study appears to confirm caffeine’s protective effect against obesity and joint disease. Image for illustration purposes
New study appears to confirm caffeine’s protective effect against obesity and joint disease. Image for illustration purposes
- Advertisement -
  • Researchers estimate that more than 1 billion people globally have obesity. 
  • Obesity can increase a person’s risk for several health problems, including joint conditions, such as osteoarthritis.
  • Scientists from Imperial College London in the United Kingdom and the University of Copenhagen in Denmark have recently found that high levels of caffeine in the blood over a long time, influenced by consumption and genetically controlled metabolism, may help protect the body against both obesity and joint disease.

According to the latest research, more than 1 billion peopleTrusted Source around the world — both adults and children — have obesity

Follow the link below to Medical News today to read the full story:

https://www.medicalnewstoday.com/articles/higher-blood-caffeine-levels-linked-to-lower-obesity-and-osteoarthritis-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-03-06&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×